The Daily Biotech Pulse: Roche’s Alzheimer’s Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Here's a roundup of top developments in the biotech space over the last 24 hours:
Roche-AC Immune’s Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer’s Patients
Roche Holdings AG (OTC:RHHBY) said its Alzheimer’s medicine crenezumab did not slow or prevent cognitive decline in people with a specific…
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax’s COVID-19 Shot, New Data On Moderna’s Omicron Vaccine, DBV Tech’s Encouraging Peanut Allergy Trial Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
One-Trick Pony Boan Biotech Files for Hong Kong IPO Into Tough Market
Key Takeaways:
Boan Biotechnology sells only one product so far and is facing stiff competition from other similar drugs
Luye Pharma bought Boan in 2020 and is taking it public at a time when markets are bearish
By Molly Wen
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced new study findings based on newly established clinical thresholds on short-acting beta-agonist (SABA) use and…
Roche Releases More Evrysdi Data For Very Young Infants With SMA
Roche Holding AG’s (OTC:RHHBY) Genentech has released new long-term data on its oral drug for spinal muscular atrophy (SMA). After three…
COVID-19 Tests Boost Roche’s Q1 Sales, Reaffirms FY22 Outlook
Roche Holdings AG’s (OTC:RHHBY) Q1 FY22 sales reached CHF 16.44 billion, +10% Y/Y to (11% at constant exchange rates) on…
EMA’ Advisory Committee Recommends Approval For Roche’s Two Cancer Drugs
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended conditional approval for Roche Holdings AG’s…
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a…
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
As any student of industry knows, Elon Musk is hardly the first person to attempt a hostile takeover.